ATAI Life Sciences BV
Biotechnology
Healthcare
ATAI
161 M shares
NASDAQ US
traded
03 Apr 2025
listed
no
open
1.37
52 week high
2.55
high
1.41
52 week low
1.06
low
1.31
growth
10.92 %
previous Close
1.48
P/E ratio
market cap
215 M
div yield
0
usd
Sep 2024
qoq
revenue
40.00 K
-85.35 %
net incoming
-26.29 M
54.14 %
eps
0.00 %
55.56 %
eps surprise
0.00 %
net profit margin
-65715.00 %
-44721.00 %
operating incoming
-22.60 M
12.15 %
net change in cash
10.63 M
2.00 %
cash on hand
29.96 M
54.98 %
cost of revenue
0.00 %
top top